News

The mainstay of therapy for the rare blood disease paroxysmal nocturnal hemoglobinuria (PNH) is Alexion's infusion therapy Soliris, but Novartis' iptacopan could provide an oral option after ...
Roche's PiaSky has been approved by the European Commission, becoming the first therapy for rare blood disorder paroxysmal nocturnal haemoglobinuria (PNH) that can be given by monthly subcutaneous ...
Some people believe that eating certain foods, including soy protein and certain kinds of grains, may benefit people with an A-positive blood type. The concept of blood-type diets was originally ...
Leukopenia is a condition where you have an abnormally low number of white blood cells (called leukocytes) due to an infection, malnutrition, autoimmune disease, drug side effects, bone marrow ...